Phase 1 Study of the Cd40 agonistic monoclonal antibody APX005M (sotigalimab) in pediatric, adolescent, and young adult patients with recurrent or progressive CNS tumors and newly diagnosed brain stem glioma: A Pediatric Brain Tumor Consortium study (PBTC-051; NCT03389802) Meeting Abstract
| Authors: | Lindsay, H. B.; Billups, C.; Baxter, P.; Hwang, E.; Lenzen, A.; MacDonald, T.; Pollack, I. F.; Robison, N.; Vinitsky, A.; Poussaint, T. Y.; Onar-Thomas, A.; Fangusaro, J.; Dunkel, I. J. |
| Abstract Title: | Phase 1 Study of the Cd40 agonistic monoclonal antibody APX005M (sotigalimab) in pediatric, adolescent, and young adult patients with recurrent or progressive CNS tumors and newly diagnosed brain stem glioma: A Pediatric Brain Tumor Consortium study (PBTC-051; NCT03389802) |
| Meeting Title: | 21st International Symposium on Pediatric Neuro-Oncology (ISPNO 2024) |
| Journal Title: | Neuro-Oncology |
| Volume: | 26 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2024 Jun 28-July 2 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001252720000247 |
| DOI: | 10.1093/neuonc/noae064.159 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TRLS-06 -- Source: Wos |
